You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Closure of Ameridose, Westborough drug company, extended 6 weeks in meningitis probe

A Westborough drug company with the same owners as the Framingham specialty pharmacy at the center of the national fungal meningitis outbreak will remain closed until at least Feb. 22, public health regulators said Thursday.

Ameridose LLC, which voluntarily ceased operations Oct. 10, will remain shuttered while a joint investigation by state and federal authorities continues into “unsanitary conditions and questionable sterility practices at the facility,” according to a statement by the Massachusetts Department of Public Health.

Continue reading below

Since October, the department has secured a series of voluntary, temporary closure agreements with Ameridose to give state and federal investigators “maximum flexibility to complete their work,” according to the statement.

A November report by federal inspectors detailed 15 problems found at Ameridose, a major hospital drug supplier, ranging from insufficient testing of the sterility and potency of the drugs it made to the presence of vermin in an area where sterile products were packaged and stored.

Ameridose agreed to recall all of its more than 2,000 products Oct. 31, after the Food and Drug Administration said it had not found “adequate assurance of sterility” during an inspection.

An Ameridose spokesman said in a statement Thursday that the company submitted an initial response to the FDA on Dec. 4 regarding the sterility and other problems inspectors found at the facility, and submitted a supplemental response on Dec. 31.

More than 650 people have been sickened, and at least 39 have died, in the fungal meningitis outbreak tied to contaminated steroids made at the New England Compounding Center.

Hospital leaders have said the closure of Ameridose has exacerbated already existing shortages of a number of medications. To address that issue, state health regulators adopted emergency regulations late last year that allow hospitals to share compounded drugs they make in their own pharmacies with other hospitals.

Kay Lazar can be reached at klazar@globe.com. Follow her on Twitter @GlobeKayLazar.
Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.